Page 55 - Merck Sharp News Today

According to nonprofit watchdog group Media Matters, 50 of the platforms top 100 advertisers, which have accounted for about $2 billion in spending since the start of 2020.

It doesn’t mean we have to buy their products. They are unAmerican. They don't support American values, especially the First Amendment.

Ranking of largest law firms and their major deals for this category.

Patients with high-risk stage III-IV melanoma who received pembrolizumab after their surgery reported a better quality of life than patients who received the previous standard-of-care treatment with either ipilimumab or high-dose interferon.

Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Imago BioSciences, Inc. (“Imago”) (Nasdaq: IMGO) today announced that the companies have entered into a definitive agreement under which Merck, through a subsidiary, will acquire Imago for $36.00 per share in cash for an approximate total ...

Acquisition expands Merck’s growing hematology portfolio ... | November 21, 2022

/PRNewswire/ -- Prasco Laboratories announced today the launch of the Authorized Generic of ZIOPTAN® (tafluprost ophthalmic solution) 0.0015%. This is Prascos...

/PRNewswire/ -- DelveInsights TIGIT Inhibitors Competitive Landscape – 2022 report provides comprehensive global coverage of available, marketed, and...

TIGIT Inhibitors clinical trial pipeline constitutes 18+ key companies continuously working towards developing 20+ TIGIT inhibitors drugs, analyzes DelveInsight LAS VEGAS, Nov. 16, 2022

Art exhibition on womens health opens in Shanghai Library East Branch-